Guidance impact on primary care prescribing rates of simple analgesia: an interrupted time series analysis in England.
analgesia
general practice
interrupted time series analysis
prescriptions
Journal
The British journal of general practice : the journal of the Royal College of General Practitioners
ISSN: 1478-5242
Titre abrégé: Br J Gen Pract
Pays: England
ID NLM: 9005323
Informations de publication
Date de publication:
2021
2021
Historique:
received:
09
04
2020
accepted:
25
08
2020
pubmed:
24
2
2021
medline:
29
6
2021
entrez:
23
2
2021
Statut:
epublish
Résumé
In March 2018, NHS England published guidance for clinical commissioning groups (CCGs) to encourage implementation of policy to reduce primary care prescriptions of over-the-counter medications, including simple analgesia. To investigate the impact of guidance publication on prescribing rates of simple analgesia (oral paracetamol, oral ibuprofen, and topical non-steroidal anti-inflammatory drugs) in primary care; CCG guidance implementation intentions; and whether the guidance has created health inequality based on socioeconomic status. Interrupted time series analysis of primary care prescribing data in England. Practice-level prescribing data from January 2015 to March 2019 were obtained from NHS Digital. Interrupted time series analyses were used to assess the association of guidance publication with prescribing rates. The association between practice-level prescribing rates and Index of Multiple Deprivation scores before and after publication was quantified using multivariable Poisson regression. Freedom of information requests were submitted to all CCGs. There was a statistically significant 4.4% reduction in prescribing of simple analgesia following guidance publication (adjusted incidence rate ratio 0.96, 95% CI = 0.92 to 0.99, Guidance publication was associated with a small reduction in the prescribing rates of simple analgesia across England, without evidence of creating additional health inequality. Careful implementation by CCGs would be required to optimise cost saving to the NHS.
Sections du résumé
BACKGROUND
In March 2018, NHS England published guidance for clinical commissioning groups (CCGs) to encourage implementation of policy to reduce primary care prescriptions of over-the-counter medications, including simple analgesia.
AIM
To investigate the impact of guidance publication on prescribing rates of simple analgesia (oral paracetamol, oral ibuprofen, and topical non-steroidal anti-inflammatory drugs) in primary care; CCG guidance implementation intentions; and whether the guidance has created health inequality based on socioeconomic status.
DESIGN AND SETTING
Interrupted time series analysis of primary care prescribing data in England.
METHOD
Practice-level prescribing data from January 2015 to March 2019 were obtained from NHS Digital. Interrupted time series analyses were used to assess the association of guidance publication with prescribing rates. The association between practice-level prescribing rates and Index of Multiple Deprivation scores before and after publication was quantified using multivariable Poisson regression. Freedom of information requests were submitted to all CCGs.
RESULTS
There was a statistically significant 4.4% reduction in prescribing of simple analgesia following guidance publication (adjusted incidence rate ratio 0.96, 95% CI = 0.92 to 0.99,
CONCLUSION
Guidance publication was associated with a small reduction in the prescribing rates of simple analgesia across England, without evidence of creating additional health inequality. Careful implementation by CCGs would be required to optimise cost saving to the NHS.
Identifiants
pubmed: 33619051
pii: bjgp20X714101
doi: 10.3399/bjgp20X714101
pmc: PMC7906621
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e201-e208Informations de copyright
© The Authors.
Références
Br J Gen Pract. 2014 Apr;64(621):e191-8
pubmed: 24686883
Br J Gen Pract. 2018 Jun;68(671):e441-e448
pubmed: 29686131
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
Cochrane Database Syst Rev. 2015 Aug 04;(8):CD006731
pubmed: 26239041
Fam Pract. 2020 Mar 25;37(2):194-199
pubmed: 31641756
Br J Clin Pharmacol. 2006 Feb;61(2):224-8
pubmed: 16433877
Eur J Public Health. 2013 Oct;23(5):732-6
pubmed: 23804080
J Antimicrob Chemother. 2018 Oct 1;73(10):2883-2892
pubmed: 29955785
BMJ Open. 2013 Aug 30;3(8):e003291
pubmed: 23996821
Br J Gen Pract. 2017 Sep;67(662):419-420
pubmed: 28860299
Aust N Z J Public Health. 2017 Apr;41(2):210-214
pubmed: 27774735
Br J Gen Pract. 2017 Nov;67(664):e800-e815
pubmed: 28993305
Br J Gen Pract. 2014 Jul;64(624):e440-7
pubmed: 24982497
J Antimicrob Chemother. 2007 Mar;59(3):537-43
pubmed: 17283035